BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Drug Development

  Femprox(R) Phase III Clinical Data From Apricus Biosciences Chosen for a Presentation at the European Society for Sexual Medicine

  November 14, 2011

   · 

  1 min read
• Business

  Rosa to Provide Noncompartmental Pharmacokinetic Analyses (NCAs) for Advanced Research Institute

  November 14, 2011

   · 

  3 min read
• The Week in Review: China National Biotech Group Schedules $2 Billion IPO in Hong Kong

  November 14, 2011

   · 

  1 min read
• Drug Development

  Ventrus Biosciences, Inc. Validates Large Patient Potential for VEN 309 With Survey Data From 10,000 Consumers

  November 14, 2011

   · 

  1 min read
• WuXi PharmaTech Co., Ltd. to Form $50 Million Venture Fund

  November 14, 2011

   · 

  1 min read
• Drug Development

  Merck & Co., Inc.'s Anti-Clotting Drug Flops in Key Trial

  November 14, 2011

   · 

  1 min read
• Bio NC

  Targacept, Inc. to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

  November 14, 2011

   · 

  1 min read
• BioCapital

  Another FDA Rejection for Alimera Sciences Eye Drug

  November 14, 2011

   · 

  1 min read
• Genetown

  Abiomed Announces Schedule of Events at American Heart Association 2011 Scientific Sessions

  November 14, 2011

   · 

  4 min read
• AxoGen, Inc. to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

  November 14, 2011

   · 

  3 min read